Seelos Therapeutics logo
Seelos Therapeutics SEEL
€ 1.21 -47.76%

Quartalsbericht 2024-Q2
hinzugefügt 14.08.2024

report update icon

Seelos Therapeutics Kennzahlen 2011-2024 | SEEL

Kennzahlen Jährlich Seelos Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.1 -1.4 -5.3 -0.4 -0.4 89.7 -2.1 -2.9 -2.5 -4.7 -2.3 -5.5

P/S

2.5 - - - 57.9 - - 2.7 11.4 5.9 31.4 8.7 24.3

EPS

-7.7 -20.7 -0.7 -0.4 -2.5 -1.1 0.8 -1.1 -3.8 -0.6 -0.5 -1.2 -0.9

EV (Enterprise Value)

41.4 M 21.8 M 38.3 M 101 M 22.6 M 4.5 M 24.8 M 25.4 M 69.1 M 56.5 M 69.7 M 75.2 M 104 M

EBITDA per Share

-8.26 -20 -0.679 -0.398 -1.44 -12 -26.6 -60.3 -126 -183 -163 -94.4 -263

EV/EBITDA

-0.6 -5.1 -0.4 0.0 -2.1 -1.5 -2.9 -2.0 -3.2 -7.1 -5.5

PEG

-0.0 -0.0 0.03 -0.08 -0.01 0.0 0.88 -0.03 -0.09 0.21 -0.08 0.08 -0.09

P/B

-0.2 -0.4 1.6 39.5 -3104.3 1.3 6.6 -2.0 -5.6 28.7 7.2 11.0 20.7

P/CF

-0.2 -0.1 - -4.9 -1.1 -0.4 -2.7 -1.2 -2.4 -3.0 -5.0 -4.9 -10.0

ROE %

113.05 693.00 -115.22 -742.65 726857.14 -359.33 7.34 98.90 191.30 -1135.28 -154.37 -479.85 -376.02

ROA %

-699.19 -323.28 -79.10 -109.19 -458.54 -245.80 4.79 -158.15 -242.18 -147.11 -72.66 -133.05 -109.04

ROCE %

120.86 668.33 -107.58 -186.38 -9236.48 -353.48 -208.33 203.11 268.86 -308.30 -162.74 -128.80 -275.66

Current Ratio

0.1 0.7 3.2 2.4 1.0 3.1 4.2 0.3 0.4 1.9 1.9 1.9 0.8

DSO

- - - - - - - 33.6 39.1 26.7 8.6 29.4 29.1

DIO

- - - - - - - 71.7 185.7 109.3 46.6 - 22.2

DPO

- - - - - - - 90.1 625.5 341.9 128.5 183.1 185.6

Betriebszyklus

- - - - - - - 105.2 224.8 136.1 55.2 29.4 51.3

Finanzkreislauf

- - - - - - - 15.2 -400.7 -205.9 -73.3 -153.7 -134.3

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Seelos Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.68 -0.2 - 0.08 -53.66 -3.58 - -0.18 -0.2 -0.13 - -0.11 -0.1 -0.28 - -0.09 -0.08 -0.14 - -0.13 -0.09 -3.98 - -0.036 -0.16 -0.21 - -0.29 -0.13 1.04 - -0.19 -0.54 -0.46 -0.05 -1 -0.1 -0.13 -0.4 -0.08 0.05 -0.09 -0.04 -0.08 -0.4 -0.29 -0.66 -0.12 -0.19 -0.2 -0.22 -0.11 -0.39 -0.18

EBITDA per Share

- - - - - - - -0.16 -0.2 -0.13 - -0.11 -0.08 -0.24 - -0.09 -0.08 -0.16 - -0.15 -0.16 -1.38 - -0.35 -0.14 -0.2 - -0.27 -0.21 -0.23 - -0.23 -0.72 -0.86 - -1.12 -0.11 -0.13 - -0.08 0.03 -0.09 - -0.08 -0.12 -0.2 - -0.06 -0.16 -0.15 - -0.09 -0.37 -0.15

ROE %

-67.07 1.53 93.01 -155.80 -370.09 -513.72 -360.60 -375.43 -141.45 -71.06 -102.75 -261.77 -405.96 -540.23 -491.87 45522.41 91695.72 118454.99 579942.86 579966.17 533975.19 507371.47 47.92 -39.75 -150.73 -195.01 63.30 80.48 185.33 263.46 94.92 118.37 151.82 160.15 191.30 -733.04 -945.88 -900.81 -1135.28 -246.65 -111.64 -245.31 -154.37 -438.72 -449.18 -487.72 -479.85 -280.64 -289.04 -376.41 -376.02 -46.08 -161.76 -70.79

ROA %

335.73 15.82 -136.07 -184.47 -401.70 -173.41 -88.01 -101.37 -46.53 -56.34 -69.38 -92.76 -102.77 -114.28 -72.32 -101.34 -106.99 -102.47 -365.86 -940.21 -1485.52 -1728.94 -1180.63 -1237.77 -720.57 -482.34 41.26 13.79 43.47 -5.57 -151.79 -181.76 -218.99 -215.37 -244.48 -331.25 -287.57 -207.49 -147.11 -36.14 -27.93 -57.48 -72.66 -149.13 -146.77 -150.52 -133.05 -79.05 -81.96 -108.24 -109.04 -13.36 -46.91 -20.53

ROCE %

112.33 124.39 107.89 -113.07 -375.48 -479.68 -332.65 -347.61 -141.61 -68.82 -90.25 -249.07 -392.93 -513.83 -502.10 52083.61 104828.15 153442.95 277385.71 277408.81 224846.20 176369.43 45.56 -39.46 -147.57 -212.36 -183.25 -160.37 -52.47 64.91 148.63 207.88 244.25 241.27 179.37 13.56 -211.51 -205.19 -285.57 -314.39 -177.41 -279.22 -121.92 -157.03 -163.32 -192.04 -156.83 -203.08 -214.21 -311.06 -279.83 -46.24 -162.51 -71.08

Current Ratio

0.1 0.1 0.1 0.2 0.2 0.5 0.7 1.2 - 2.8 3.2 10.1 11.9 2.5 1.2 1.2 1.2 1.2 1.0 1.0 1.0 1.0 0.0 0.0 0.0 0.0 2.9 2.9 2.9 2.9 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 1.1 1.1 1.1 1.1 1.9 1.9 1.7 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4

DSO

140.3 136.4 - 73.3 166.2 44.8 - - - - - - - - - - - - - - - - - - - - - - - - - 11.5 135.2 88.0 18.0 37.2 102.5 115.0 32.4 32.6 11.3 - 14.9 192.3 4.5 34.9 25.0 12.2 20242.3 47.7 132.3 37.3 18.7 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

140.3 136.4 - 73.3 166.2 44.8 - - - - - - - - - - - - - - - - - - - - - - - - - 11.5 135.2 88.0 18.0 37.2 102.5 115.0 32.4 32.6 11.3 - 14.9 192.3 4.5 34.9 25.0 12.2 20242.3 47.7 132.3 37.3 18.7 -

Finanzkreislauf

140.3 136.4 - 73.3 166.2 44.8 - - - - - - - - - - - - - - - - - - - - - - - - - 11.5 135.2 88.0 18.0 37.2 102.5 115.0 32.4 32.6 11.3 - 14.9 192.3 4.5 34.9 25.0 12.2 20242.3 47.7 132.3 37.3 18.7 -

Alle Zahlen in USD-Währung